RxDoctor Payments Data

Michael Theodoulou

Podiatrist · Somerville, MANPI 1760430755

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $157,155 of the $209,906 with a category attached, or 74.9%. 35 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 51.2% of the total. 2025 is the largest year on record at $57,334, 3.0 times the $19,127 reported in 2019. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$209,906in general payments, 2019–2025

Across 307 payments — averaging $683.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$107K
  • Integra Lifesciences Corporation$57K
  • Avitus Orthopaedics, Inc.$15K
  • Arthrex$14K
  • Kairos Surgical Inc$6K
  • Wishbone Medical Inc.$4K
  • plus $7K from 29 others

What the payments were for

  • Consulting fees$157,15575%
  • Speaking & faculty fees$12,1196%
  • Travel & lodging$25,76112%
  • Food & beverage$8,7594%
  • Education$6,1113%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$209,906 in reported general payments places this provider in the 95th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$58,900
Medicare patients
272
Services billed
552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium20$1,042
Ammonium Lactate26$763
Gabapentin39$292
Clotrimazole12$219
Terbinafine Hcl17$148

Paid to pharmacies, not to this prescriber.

Other podiatrist in Somerville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →